(IN BRIEF) Sanofi has completed the acquisition of DR-0201 from Dren Bio, now renamed SAR448501, to enhance its immunology pipeline. This bispecific myeloid cell engager, which has shown promising results in B-cell depletion, may offer potential breakthroughs in autoimmune diseases, … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Investment, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged acquisition, antibody therapeutics, autoimmune diseases, B cell depletion, biopharmaceuticals, bispecific myeloid cell engager, clinical-stage, DR-0201, Dren Bio, immunology, lupus, partnership, phagocytosis, Sanofi, SAR448501, therapeutics
(IN BRIEF) Merck has entered into a definitive agreement to acquire SpringWorks Therapeutics for approximately $3.9 billion. This acquisition will significantly enhance Merck’s rare tumor portfolio, adding first-in-class therapies for desmoid tumors and NF1-PN. The deal aligns with Merck’s strategy … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged acquisition, biopharmaceuticals, cancer treatments, desmoid tumors, Healthcare Innovation, M&A, Merck, NF1-PN, partnership, pharmaceutical acquisition, rare tumors, SpringWorks Therapeutics, U.S. healthcare
(IN BRIEF) Basilea Pharmaceutica has received a CHF 1.7 million milestone payment from its partner Asahi Kasei Pharma following continued strong sales of Cresemba® in Japan—marking the second consecutive quarterly milestone. Cresemba, now marketed in over 70 countries, achieved USD … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged AKP, antifungal treatment, Asahi Kasei Pharma, aspergillosis, azole antifungal, Basilea Pharmaceutica, biopharmaceuticals, branded antifungal leader, Cresemba®, cryptococcosis, David Veitch, fungal infection therapies, global antifungal sales, intravenous antifungal, invasive fungal infections, Isavuconazole, Japan pharmaceutical market, Japanese drug market, milestone payment, mucormycosis, oral antifungal, partnership
(IN BRIEF) Boehringer Ingelheim has begun construction on a new Chemical Innovation Plant at its headquarters in Ingelheim, Germany. The €285 million investment will develop manufacturing processes for active pharmaceutical ingredients and produce drugs for clinical trial phases, enabling Boehringer … Read the full press release
(PRESS RELEASE) CAMBRIDGE, 5-Jun-2020 — /EuropaWire/ — British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca announced it will present new data across continuum of care from its broad renal portfolio during the 57th virtual congress of the European Renal Association – … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Society, United Kingdom
Tagged 57th European Renal Association, AstraZeneca, biopharmaceuticals, Chronic kidney disease, European Dialysis, Farxiga, FibroGen, haemodialysis, Hyperkalaemia, Lokelma, renal care, renal medicines, roxadustat, Ruud Dobber, Transplant Association
(PRESS RELEASE) GENEVA, 29-May-2020 — /EuropaWire/ — Leading bio/pharmaceutical analytical and bioanalytical contract solutions provider SGS announces the appointment of Edward R. Zartler, Ph.D as Director of Biopharmaceutical Services (USA). Edward, who joined SGS in May 2020, takes responsibility for … Read the full press release
Posted in Business, Healthcare, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged analytical, bioanalytical, biologics business, Biopharmaceutical Services, biopharmaceuticals, certification, Complex Carbohydrate Research Center, Edward R. Zartler Ph.D, Goucher College, inspection, Josée Leach, laboratories, Life Science Services, Pharmaceutical, SGS, SGS Life Sciences, testing, University of Georgia, University of Pennsylvania, verification, Vipan Dhall
(PRESS RELEASE) BERLIN, 14-Aug-2019 — /EuropaWire/ — The Parenteral Drug Association (PDA) today announced representatives of seven health authorities have been invited to speak at the 2019 PDA Europe Biomanufacturing Conference, 3-4 September 2019 in Munich, Germany. The following health … Read the full press release
Posted in Denmark, France, Germany, Healthcare, Italy, Media, Netherlands, News, Pharma & Biotech, Science, Spain, Sweden, United Kingdom
Tagged Accelerated Access, biopharmaceuticals, Continuous Manufacturing, Danish Medicines Agency, Dolores Hernan, Dutch Medicines Evaluation Board, European Directorate for the Quality of Medicines & Healthcare (EDQM), European Medicines Agency, GMP, Gwenael Cirefice, Manufacturing, Martjin van der Plas, Mats Welin, medicines, Nanna Kruse, PDA, Regulation, Swedish Medicines Agency
EMA, MHRA and FDA among regulatory agencies participating (PRESS RELEASE) BERLIN, 10-Jun-2019 — /EuropaWire/ — The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting: Global Healthcare of the Present and the Future, June 25-26 in … Read the full press release
Posted in France, Germany, Healthcare, Ireland, Media, Netherlands, News, Pharma & Biotech, Science, Switzerland, United Kingdom
Tagged 4th PDA European Annual Meeting, Amsterdam, automation, Basel, Berlin, biopharmaceuticals, data quality management, data science, digitalization, Dublin, EMA, European Medicines Agency, FDA, Felix G. Rebitschek, Healthcare, HPRA, London, Manufacturing, manufacturing technologies, Max Planck Institute, medicines, MHRA, Paris, PDA, pharmaceuticals, PIC/S, regulators, Virtual Reality, Walter Morris, WHO, Zurich
STOCKHOLM, 04-Jun-2018 — /EuropaWire/ — EQT Credit, through its Mid-Market investment strategy, is pleased to announce that it has provided the financing to support Keensight Capital and ERES’ (the “Shareholders”) investment in Biovian (or the “Company”), a leading European player in … Read the full press release
Posted in Financial, Finland, Investment, Pharma & Biotech, Sweden
Tagged acquisition, biopharmaceuticals, Biovian, EQT Credit, ERES, financing, investment, Keensight Capital, Paul Johnson
WACKER TAKES OVER SYNCO BIO PARTNERS OF AMSTERDAM CAPACITY OF ACQUIRED FERMENTATION PLANT FOR PHARMACEUTICAL ACTIVES TOTALS SOME 2,000 LITERS – WACKER BIOTECH’S OVERALL CAPACITY DOUBLES AS A RESULT SYNCO’S EXPERTISE IN MANUFACTURING LIVE MICROBIAL PRODUCTS AND IN FILLING FINISHED … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?